Effect of devascularization and shunt on liver transplantation in patients with portal hypertension
-
摘要:
目的 探讨门静脉高压症患者行断流术及分流术对其行肝移植的影响。 方法 回顾性分析2007年1月至2011年12月中山大学附属第三医院器官移植中心收治的182例肝硬化、门静脉高压症伴食道胃底静脉曲张出血史的肝移植患者的临床资料。将肝移植前行脾切除+贲门周围血管离断术19例设为断流术组,行远端脾-肾静脉分流术5例设为分流术组,其余无断流或分流手术史的158例作为对照组。比较3组受者在肝移植术前门静脉血栓形成发生率、手术时间、术中出血量、术后1个月门静脉吻合口最大血流速度(Vmax)、术后门静脉血栓形成发生率及3年存活率等方面的差异。 结果 断流术组受者术前门静脉血栓形成的发生率明显高于对照组(P < 0.01)。与对照组比较,断流术组、分流术组的肝移植手术时间均明显增加(均为P < 0.05),断流术组术后1个月门静脉血栓形成的发生率明显升高(P < 0.05)。断流术组、分流术组的3年存活率明显降低(均为P < 0.05)。3组受者的术中出血量及术后1个月门静脉吻合口Vmax比较差异均无统计学意义(均为P>0.05)。 结论 门静脉高压症患者既往接受的断流术或分流术不会给后续的肝移植造成严重的困难或风险。 Abstract:Objective To evaluate the influence of devascularization and shunt on liver transplantation in patients diagnosed with portal hypertension. Methods Clinical data of 182 patients diagnosed with cirrhosis, portal hypertension complicated with hemorrhages caused by esophageal and gastric varices rupture undergoing liver transplantation in the Third Affiliated Hospital of Sun Yat-sen University from January 2007 to December 2011 were retrospectively analyzed. Nineteen patients undergoing splenectomy plus pericardial devascularization were assigned into the devascularization group, 5 receiving distal spleen-renal vein shunt into the shunt group, and the remaining 158 cases with no history of devascularization or shunt into the control group. Preoperative incidence of pylethrombosis, operation time, intraoperative hemorrhage volume, the maximal blood flow velocity (Vmax) of portal vein anastomotic stoma at postoperative 1 month, postoperative incidence of pylethrombosis and 3-year survival rate were statistically compared among three groups. Results In the devascularization group, preoperative incidence of pylethrombosis was significantly higher compared with that in the control group(P < 0.01). Compared with the control group, operation time of liver transplantation in the devascularization and shunt groups was significantly longer (both P < 0.05). The incidence of pylethrombosis at postoperative 1 month was considerably enhanced in the devascularization group (P < 0.05). The 3-year survival rates of devascularization group and shunt group were dramatically decreased compared with that of control group (both P < 0.05). Intraoperative hemorrhage volume and Vmax of portal vein anastomotic stoma did not significantly differ among three groups (all P>0.05). Conclusions The medical history of devascularization or shunt will not cause severe difficulty or surgical risk to subsequent liver transplantation in patients with portal hypertension. -
Key words:
- Liver transplantation /
- Portal hypertension /
- Devascularization /
- Shunt
-
[1] Otto G. Liver transplantation: an appraisal of the present situation[J]. Dig Dis, 2013, 31(1):164-169. doi: 10.1159/000347213 [2] 冷希圣.门静脉高压症治疗的现状与展望[J].中国普外基础与临床杂志, 2013, 20(1):1-3. http://www.cnki.com.cn/Article/CJFDTOTAL-ZGWK200905036.htmLeng XS. Current status and perspectives in the management of portal hypertension[J]. Chin J Bases Clin Gen Surg, 2013, 20(1):1-3. http://www.cnki.com.cn/Article/CJFDTOTAL-ZGWK200905036.htm [3] 周光文.肝移植时代门静脉高压症外科手术方式的选择[J].中国普外基础与临床杂志, 2013, 20(1):10-12. http://www.cnki.com.cn/Article/CJFDTOTAL-ZPWL201301003.htmZhou GW. The choice of surgical module for the treatment of portal hypertension in the era of liver transplantation[J]. Chin J Bases Clin Gen Surg, 2013, 20(1):10-12. http://www.cnki.com.cn/Article/CJFDTOTAL-ZPWL201301003.htm [4] Pal S. Current role of surgery in portal hypertension[J]. Indian J Surg, 2012, 74(1):55-66. doi: 10.1007/s12262-011-0381-8 [5] 李宗芳, 蒋安, 张澍, 等.肝硬化门静脉高压症个体化治疗策略的探索与实践[J/CD].中华肝脏外科手术学电子杂志, 2015, 4(3):146-149.Li ZF, Jiang A, Zhang S, et al. Exploration and practice on individualized treatment strategies of liver cirrhosis portal hypertension[J/CD]. Chin J Hepatic Surg(Electr Edit), 2015, 4(3): 146-149. [6] 沈丛欢, 夏强, 徐宁, 等.肝硬化伴门静脉血栓患者行肝移植术的处理[J].肝胆外科杂志, 2011, 19(4):254-257. http://www.cnki.com.cn/Article/CJFDTOTAL-GDWZ201104007.htmShen CH, Xia Q, Xu N, et al. Management of portal vein thrombosis in patients with cirrhosis in the liver transplantation[J]. J Hepatobiliary Surg, 2011, 19(4):254-257. http://www.cnki.com.cn/Article/CJFDTOTAL-GDWZ201104007.htm [7] Suarez Artacho G, Barrera Pulido L, Alamo Martinez JM, et al. Outcomes of liver transplantation in candidates with portal vein thrombosis[J]. Transplant Proc, 2010, 42(8):3156-3158. http://www.doc88.com/p-9902182151178.html [8] 张本厚, 王桂芳, 池萍, 等.门脉高压症术后抗凝治疗下门静脉血栓形成的因素分析[J].西安交通大学学报(医学版), 2015, 36(4):565-567. http://www.cnki.com.cn/Article/CJFDTOTAL-XAYX201504028.htmZhang BH, Wang GF, Shi P, et al. Risk factors for portal venous thrombosis under anticoagulation therapy after operation of portal hypertension[J]. J Xi'an Jiaotong University(Med Sci), 2015, 36(4):565-567. http://www.cnki.com.cn/Article/CJFDTOTAL-XAYX201504028.htm [9] Li MX, Zhang XF, Liu ZW, et al. Risk factors and clinical characteristics of portal vein thrombosis after splenectomy inpatients with liver cirrhosis[J]. Hepatobiliary Pancreat Dis Int, 2013, 12(5):512-519. http://en.cnki.com.cn/Article_en/CJFDTOTAL-GJGD201305012.htm [10] Lai Q, Spoletini G, Pinheiro RS, et al. From portal to splanchnic venous thrombosis: what surgeons should bear in mind[J]. World J Hepatol, 2014, 6(8):549-558. http://www.cqvip.com/qk/71422x/201408/1005328830.html [11] Zheng X, Liu Q, Yao Y. Laparoscopic splenectomy and esophagogastric devascularization is a safe, effective, minimally invasive alternative for the treatment of portal hypertension with refractory variceal bleeding[J]. Surg Innov, 2013, 20(1):32-39. doi: 10.1177/1553350612441863 [12] Biecker E. Portal hypertension and gastrointestinal bleeding: diagnosis, prevention and management[J]. World J Gastroenterol, 2013, 19(31):5035-5050. doi: 10.3748/wjg.v19.i31.5035 [13] 刘佳, 张绍庚, 肖朝辉, 等.手助腹腔镜改良Sugiura术治疗门静脉高压症的临床分析[J].中国普通外科杂志, 2013, 22(2):197-200. http://www.cnki.com.cn/Article/CJFDTOTAL-ZPWZ201302017.htmLiu J, Zhang SG, Xiao ZH, et al. Clinical analysis of hand-assisted laparoscopic modified Sugiura procedure for portal hypertension[J]. Chin J Gen Surg, 2013, 22(2):197-200. http://www.cnki.com.cn/Article/CJFDTOTAL-ZPWZ201302017.htm [14] 鲁建国, 阴继凯.腹腔镜外科时代门脉高压症的治疗现状与展望[J].肝胆外科杂志, 2013, 21(6):406-409. http://www.cnki.com.cn/Article/CJFDTOTAL-GDWZ201306004.htmLu JG, Yin JK. Status quo and prospect of the treatment of portal hypertension in laparoscopic surgery time[J]. J Hepatobiliary Surg, 2013, 21(6):406-409. http://www.cnki.com.cn/Article/CJFDTOTAL-GDWZ201306004.htm [15] Gur I, Diggs BS, Orloff SL. Surgical portosystemic shunts in the era of TIPS and liver transplantation are still relevant[J]. HPB, 2014, 16(5):481-493. doi: 10.1111/hpb.12163 [16] Orloff MJ, Vaida F, Haynes KS, et al. Randomized controlled trial of emergency transjugular intrahepatic portosystemic shunt versus emergency portacaval shunt treatment of acute bleeding esophageal varices in cirrhosis[J]. J Gastrointest Surg, 2012, 16(11):2094-2111. doi: 10.1007/s11605-012-2003-6 [17] Feng G, Jing C, Qian Z, et al. Use of a gastrojugular shunt as a less invasive portal systemic shunt before liver transplantation[J]. Liver Transpl, 2014, 20(7):864-866. doi: 10.1002/lt.v20.7
点击查看大图
计量
- 文章访问数: 161
- HTML全文浏览量: 91
- PDF下载量: 5
- 被引次数: 0